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(57) ABSTRACT 
Crystal growth can be initiated and controlled by dynami- 
cally controlled vapor diffusion or temperature change. In 
one aspect, the present invention uses a precisely controlled 
vapor diffusion approach to monitor and control protein 
crystal growth. The system utilizes a humidity sensor and 
various interfaces under computer control to effect virtually 
any evaporation rate from a number of different growth 
solutions simultaneously by means of an evaporative gas 
flow. A static laser light scattering sensor can be used to 
detect aggregation events and trigger a change in the evapo- 
ration rate for a growth solution. A controlifollower con- 
figuration can be used to actively monitor one chamber and 
accurately control replicate chambers relative to the control 
chamber. In a second aspect, the invention exploits the 
varying solubility of proteins versus temperature to control 
the growth of protein crystals. This system contains minia- 
ture thermoelectric devices under microcomputer control 
that change temperature as needed to grow crystals of a 
given protein. Complex temperature ramps are possible 
using this approach. Astatic laser light scattering probe also 
can be used in this system as a non-invasive probe for 
detection of aggregation events. The automated dynamic 
control system provides systematic and predictable 
responses with regard to crystal size. These systems can be 
used for microgravity crystallization projects, for example in 
a space shuttle, and for crystallization work under terrestial 
conditions. The present invention is particularly useful for 
macromolecular crystallization, e.g.  for proteins, 
polypeptides, nucleic acids, viruses and virus particles. 
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DYNAMICALLY CONTROLLED CRYSTAL 
GROWTH SYSTEM 
This application is a continuation of application Ser. No. 
081719,481, filed Sep. 25, 1996 now abandoned, based on 
provisional application Ser. No. 601004,267, filed Sep. 25, 
1995, which applications are incorporated herein by refer- 
ence. 
GOVERNMENT CONTRACT INFORMATION 
The work reflected in this application was supported by 
NASA contract NAS8-40189. 
BACKGROUND OF THE INVENTION 
Protein structural information has proven beneficial for 
understanding structure1function relationships and for appli- 
cations such as structure-based drug design. X-ray crystal- 
lography is the predominant technique used to obtain three- 
dimensional protein structure information. A critical 
component of this technique is the growth of high quality, 
well ordered crystals of the target protein. Advances in x-ray 
diffraction equipment, data collection methods, and compu- 
tational capabilities have progressed to the point where the 
growth of high quality crystals is often the rate limiting step 
for the determination of three-dimensional protein struc- 
tures. Many different techniques have been used in the 
attempt to grow high quality protein crystals. The most 
widely used protein crystal growth technique, vapor 
diffusion, utilizes a growth solution containing protein and 
a precipitating agent. A popular vapor diffusion 
configuration, typically described as the hanging-drop or 
Linbro method (McPherson, Jr., A. (1982), Preparation and 
Analysis of Protein Crystals (Wiley, New York)-see FIG. 
l), uses a reservoir solution containing precipitant and a 
buffered protein1precipitant solution that “hangs” from a 
sealed cover slip positioned over the reservoir. The initial 
solution conditions are such that water vapor diffuses from 
the protein solution into the reservoir solution, thereby 
increasing the concentration of the protein beyond its solu- 
bility point. One significant limitation of the traditional 
vapor diffusion technique is that the evaporation of water 
from the growth solution (within a particular geometry) is 
fixed by the starting concentrations of the solution compo- 
nents (see FIG. 2). Thus, the rate at which the approach to 
supersaturation of the growth solution occurs is fixed, even 
if modification of this evaporation rate is desirable, and this 
technique suffers from the inability to control the vapor 
equilibration process once the experiment is initiated. 
The vapor diffusion technique has been used successfully 
to grow protein crystals in the microgravity environment of 
NASA’s Space Shuttle, with space flight hardware called the 
Vapor Diffusion Apparatus or VDA, (Herrmainn, F. T., and 
Herren, B. J. (1990) “Crystal Growth Apparatus”, U.S. Pat. 
No. 4,919,899 andSnyder, R. S.; Herren, B. J.; Carter, D. C.; 
Yost, V. H.; Bugg, C. E.; DeLucas, L. J.; Suddath, F. L. 
(1991) “Macromolecular Growing Sytems”, U.S. Pat. No. 
5,013,531). The original Vapor Diffusion Apparatus (VDA) 
was used to grow protein crystals in the microgravity 
environment of NASA’s Space Shuttle. However, its con- 
cept and design have proven not to be optimal and it has 
specific limitations. For example, during crystal growth and 
nucleation, the vapor diffusion profile is fixed by the starting 
solution concentrations. Also no modification of the experi- 
ment is possible and photography during crystal growth is 
sporadic and non-isothermal. Although significant, the 
results with the Vapor Diffusion Apparatus are not optimal 
2 
as evidenced by the following statistics. Only 25% of all 
proteins flown in the VDA produced crystals that diffracted 
better than any crystals grown on Earth. 40% of protein 
flown produced crystals which did not diffract better and 
5 35% produced no crystals. Clearly there is need for methods 
and devices to improve the success ratio. Also, investiga- 
tions have been underway (Smith, H. W. & DeLucas, L. J. 
(1991), J. Crystal Growth 110 137; Wilson, L. J. & Suddath, 
F. L. (1992), J. Crystal Growth 116 414) in the attempt to 
produce systems that will allow control over the evaporation 
profile of a growth solution. Early experiments showed that 
simply slowing down the evaporation rate of a growth 
solution generally produces a smaller population of larger 
crystals than can be obtained with traditional vapor diffusion 
1~ techniques. Recent results from a large number of experi- 
ments shows this effect to be consistent not only for 
lysozyme, but for other proteins as well. 
While vapor diffusion has been (and still is) a very 
popular technique, it has not always proven to be the best 
20 method for a given protein, and hence a wide range of other 
approaches have been used as a means to obtain high quality 
protein crystals. Another protein crystal growth technique, 
temperature, has only begun to be extensively explored in 
recent years. This technique utilizes the variable solubility 
2s versus temperature that some proteins exhibit for a given 
solution condition as a means for initiating and controlling 
crystal growth. Though this approach offers promise when 
compared to other techniques for controlling the rate of 
growth to produce high quality protein crystals, this method 
30 is not without limitations. Several proteins have been crys- 
tallized successfully using temperature (Baker, E. N. and 
Dodson, G. (1970), J. Mol. Biol. 54, 605; Shotton, D. M. , 
Hartley, B. S., Camerman, N. and Hofnab, T. (1968), J. Mol. 
Biol. 32, 155; Hanson, A. W., Applebury, M. L., Coleman, 
35 J. E. and Wyckoff, H. (1970), J. Biol. Chem. 245, 4975; 
McPherson, JR., A. and Rich, A. (1972), Biochem. Biophys. 
Acta 285, 493), and recent developments in custom instru- 
mentation and devices that screen protein solubility versus 
temperature improve the usefulness of temperature as a 
40 strategic method for growing protein crystals (Cacioppo, E., 
Munson, S. and Pusey, M. L. (1991), J. Crystal Growth 110, 
66). 
Despite this, the approach to finding suitable conditions 
that yield high quality protein crystals predominantly has 
45 been a trial and error process, where more than one thousand 
crystallization conditions are typically screened, often with- 
out success. Several systems have been constructed to aid 
the growth of protein crystals. These systems vary in com- 
plexity from simple hand-held devices (Eisele, J.-L. (1993), 
SO J. Appl. Cryst. 26, 92) to complex robotic systems that 
simply prepare and monitor different conditions (Cox, M. J. 
and Weber, P. C. (1988), J. Crystal Growth 90,318; Chayen, 
N. E., Stewart, P. D. S., Maeder, D. L. and Blow, D. M. 
(1990), J. Appl. Cryst. 23, 297). Only a few systems have 
ss attempted to achieve control over the dynamics of protein 
crystal growth (Wilson, L. J., Bray, T. L. and Suddath, F. L. 
(1991), J. Crystal Growth 110, 142; Casey, G. A. and 
Wilson, W. W. (1992), J. Crystal Growth 122,95) by altering 
the rate at which water is removed from the growth solution. 
60 Other investigations have been underway (Smith, H. W. and 
DeLucas, L. J. (1991), J. Crystal Growth 110, 137; Wilson, 
L. J. and Suddath, F. L. (1992), J. Crystal Growth 116, 414) 
in the attempt to produce systems that will allow control 
over the evaporation profile of a growth solution. Early 
65 experiments showed that simply slowing down the evapo- 
ration rate of a growth solution generally produces a smaller 
population of larger crystals than can be obtained with 
US 6,406,903 B2 
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traditional vapor diffusion techniques. However, they have 
not offered true dynamic control of the protein crystal 
growth process. 
SUMMARY OF THE INVENTION 
The present invention provides a system for dynamic 
control of crystal growth, particularly for difficult-to- 
crystallize macromolecular substances such as proteins, 
polypeptides, nucleic acids, viruses and virus fragments. 
The nucleic acids include DNA, RNA and fragments of 
DNA and RNA. While reference is made hereafter to protein 
crystal growth, it should be understood that these teachnigs 
will be equally applicable to other macromolecular sub- 
stances. Dynamic control of protein crystal growth (DC/ 
PCG) has operational advantages that include the ability to 
separate protein crystal aggregation and/or nucleation from 
the post nucleation protein crystal growth phase and the 
potential for limiting the number of nucleation sites. Super- 
saturation conditions necessary for the aggregation and /or 
nucleation of proteins are often significantly greater than 
those needed for subsequent growth of the crystal. In order 
to minimize problems during the subsequent growth phase 
caused by the higher supersaturation necessary for 
nucleation, it is desirable to separately control the nucleation 
and growth environments. With DCIPCG, one has the capa- 
bility to vary post-nucleation growth kinetics. One also has 
the capability to optimize crystal growth conditions in 
subsequent experiments. With respect to microgravity 
experiments, DCPCG also minimizes protein sample quan- 
tities and minimizes astronaut crew time in experiment 
operation. 
The present invention provides systems with increased 
capacity and versatility for the growth of protein crystals by 
vapor diffusion or temperature. Temperature adjustments are 
advantageous in providing a non-invasive means of control- 
ling the supersaturation environment of protein nuclei. 
Additionally, laser light scattering data from the growth 
medium allows the aggregation state of the protein to be 
evaluated non-invasively and provides for dynamic control 
of the crystallization process. These systems achieve truly 
dynamically controlled protein crystal growth system that 
can be used for both terrestrial and microgravity experi- 
ments. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 illustrates a Linbro box hanging drop vapor 
diffusion chamber of the prior art. 
FIG. 2 is a graph showing drop volume versus time for a 
typical vapor diffusion experiment in a Linbro box. 
FIG. 3 is a block diagram of an example for dynamic 
control protein crystal growth (DCPCG) via vapor diffusion 
with evaporation rate controlled by nitrogen gas flow. 
FIG. 4 is a schematic illustration of a dynamically con- 
trolled vapor diffusion system. 
FIGS. 5(a) and (b) show a thermal conductivity humidity 
detector and its circuit. 
FIG. 6 is an enlarged illustration of one of the elements 
shown in FIG. 4. 
FIG. 7 is a flowchart for software for controlling the vapor 
diffusion system. 
FIG. 8 is a sectional side view of a crystal growth chamber 
used in the system of FIGS. 4 and 6. 
FIGS. 9(a) and (b) show lysozyme crystal growth results 
at varying evaporation rates. 
FIGS. lO(a) and (b) show thaumatin crystal growth 
results at varying evaporation rates. 
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FIG. 11 illustrates an example of a dynamically controlled 
vapor diffusion controlifollower system. 
FIG. 12 illustrates a further example of a crystal growth 
chamber. 
FIG. 13 shows evaporation profiles overlaying typical 
static laser light scattering signal as aggregation occurs. 
FIG. 14 shows results for lysozyme crystal growth at 
different evaporation rates, under conditions where the 
evaporation was terminated upon detection of aggregation 
and/or nucleation (triggered) and where evaporation contin- 
ued after the onset of nucleation (non-triggered). 
FIG. 15 is a block diagram of a system for dynamic 
control protein crystal growth (DCIPCG) via temperature 
induction. 
FIG. 16 is an enlarged view of a growth chamber from the 
system of FIG. 14. 
FIG. 17 is a scematic illustration of a dynamically con- 
trolled temperature system. 
FIG. 18 is a schematic illustration of laser light scattering 
with nucleation chamber. 
FIG. 19 is circuit diagram for a temperature controller that 
can be used with the controlled temperature system. 
FIG. 20 is a flowchart for software for controlling the 
controlled temperature system. 
FIGS. 21(a)<d) show examples of computer generated 
temperature profiles useful with the temperature induction 
protein crystal growth systems. 
FIGS. 22(a)-(d) show plots of voltage and solution tem- 
perature versus experiment time for lysozyme crystals. 
FIGS. 23(a)-(d) are micrographs showing lysozyme crys- 
tals obtained from experiments whose results are graphed in 
FIGS. 22(a)-(d). 
FIGS. 24(a) and (b) show plots of voltage and solution 
temperature versus .experiment time for bovine insulin 
aggregates and/or nuclei. 
FIGS. 24(c) and (d) show plots of voltage and solution 
temperature versus experiment time for porcine insulin 
aggregates and/or nuclei. 
FIG. 25 shows temperature crystallization data for the 
protein neurophysin. 
FIG. 26 illustrates a dynamically controlled temperature 
controlifollower system. 
FIG. 27 shows details of the controlifollower system. 
FIGS. 28(a) and (b) show results from crystallization of 
lysozyme with a modified version of the temperature crystal 
growth method. 
FIG. 29 is a diagram of an example of an interface 
between the Space Shuttle (STS) and a vapor diffusion 
dynamically controlled protein crystal growth system. 
FIG. 30 is a diagram of an example of an interface 
between the Space Shuttle (STS) and a temperature induc- 
tion dynamically controlled protein crystal growth system. 
DETAILED DESCRIPTION 
The disclosure of U.S. Ser. No. 081432,914 filed May 1, 
1995 is incorporated herein by reference in its entirety. 
The present invention is directed to a method and appa- 
ratus for the dynamic control of the crystal growth process. 
In particular, the present invention is directed to crystal 
growth systems based on vapor diffusion or temperature 
changes for initiating crystallization from a solution. While 
the present invention is useful for crystallization of inor- 
ganic and organic substances in general, the present inven- 
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tion is particularly useful for crystallization of macromo- 
lecular substances such as proteins, polypeptides, nucleic 
acids (for example DNA, RNA and fragment of DNA and 
RNA), viruses and virus fragments, especially proteins. The 
present invention is useful in crystallization studies for 
structure-based drug design targets and for determining 
structures of substances to be inhibited in treating diseases. 
In addition, the present invention is useful for work with 
complexes of various macromolecular substances, for 
example with inhibitors, and such related substances should 
be considered to included in the definition of the macromo- 
lecular substances. 
Ordinarily, for macromolecular substances the substance 
to be crystallized will be dissolved in water, but the present 
invention is equally useful for other solvents as needed. The 
dynamic control of the present invention can be based on 
feedback obtained by observation of the solution being 
crystallized. Such feedback can be obtained by using moni- 
toring techniques such as laser light scattering, real time 
video , turbidity measurements, interferometry, diffraction, 
ultrasonography, scintillation, polarization, schlieren optics, 
ellipsometry, holography and raman spectroscopy. It will be 
noted that some of these monitoring systems, e.g. laser light 
scattering, are not capable of distinguishing between aggre- 
gation and nucleation in the solution. This is not critical in 
the context of the present invention, and the detection of 
either event is suitable. The present invention can be used 
advantageously for microgravity crystallization work, for 
example in the Space Shuttle, as well as for terrestial work. 
Vapor Diffusion Based Systems 
The present invention can provide dynamic control for 
crystallization in the traditional “hanging drop” type con- 
figuration as well as in a “container” configuration. In each 
case, the solvent evaporation rate can be controlled carefully 
to respond to the progression of the crystallization. The 
solvent evaporation rate can be controlled by means of a 
variable gas flow. It is particularly desirable to avoid having 
the gas flow impinge directly upon the crystallization solu- 
tion. One way to accomplish this is to have the crystalliza- 
tion reaction chamber separated into two sections, a solvent 
evaporation section and a purging section, separated by a 
barrier that substantially prevents direct impingement of the 
gas flow from the purging section on the crystallization 
solution but permits passage of solvent vapor. The rate of 
solvent evaporation from the crystallization solution can be 
controlled by varying the gas flow through the purging 
section. 
The removal of solvent from the crystal growth solution 
can be checked by monitoring the gas removed from the 
purging section. In the case of an aqueous solvent, this can 
be done by monitoring the relative humidity of the purged 
gas. It is possible to multiplex a number of reaction cham- 
bers to one humidity sensor, allowing a large number of 
experiments to be performed simultaneously. It also is 
possible to handle a number of reaction chambers using a 
“controlifollower” concept, where one chamber (the control) 
is monitored actively and other chambers (the followers) are 
acted upon in response to events occurring in the control 
chamber. A static laser light scattering system is one 
example of a useful a sensor for detecting aggregation 
events occurring in growth solutions to trigger a response, 
such as changing the evaporation rate of one or more of the 
crystal growth solutions. Laser light scattering is an impor- 
tant diagnostic tool to monitor protein crystal nucleation. It 
constitutes a sensitive, nonintrusive and real-time diagnostic 
for dynamic control of protein crystal growth. It can be 
6 
adapted for most protein crystal growth configurations and 
can provide predictive information important to protein 
crystal growth. 
A first example of a dynamically controlled vapor diffu- 
5 sion system (DCVDS) is based on the “hanging drop” vapor 
diffusion methods that have yielded relatively high success 
rates for obtaining protein crystals. This system incorporates 
a controlled flow of gas, dry nitrogen (N,) gas as one 
example, instead of a reservoir solution to extract water, via 
10 the vapor phase, from the growth solution. This allows 
precise control over the rate at which the growth solution 
“equilibrates.” In the traditional “hanging drop” vapor dif- 
fusion experiment, water diffuses rapidly during the early 
stages of the experiment and subsequently slows down 
15 asymptotically as the experiment progresses. Depending 
upon the solution components, complete equilibration can 
occur over a range of 3 to 30 days (Fowlis et al., (1988), J. 
Crystal Growth 90, 117). The present system described 
allows the equilibration rate to be varied at virtually any rate. 
20 While nitrogen gas is useful, other gases can be used as 
desired, and examples include non-reactive gases such as 
He, Ne, Xe, Ar and Kr. In addition, other gases such as CO, 
can be used if they do not have an adverse impact on the 
solution being crystallized, or if measures are taken to 
25 reduce any adverse impact such as buffering against pH 
changes. 
FIG. 3 is a block diagram of a suitable system for protein 
crystal growth effected by vapor diffusion with nitrogen gas 
to control the evaporation rate. The sample chamber can be 
30 instrumented with laser light scattering (LLS), video moni- 
toring and a humidity detector to moderate nitrogen flow. 
The growth occurs under constant temperature conditions 
via isothermal temperature control. The system may be 
monitored and controlled by computer. 
Referring now to FIG. 4, the system screens up to 40 
different evaporation profiles simultaneously, using growth 
chambers in which the growth solution is deployed as a 
hanging drop. Gas flow in and out of each chamber is 
4o controlled by a pair of valves (available for example from 
Lee Company of West Brook Connecticut). The amount of 
water evaporated from each growth solution at any given 
time is measured quantitatively using a microvolume ther- 
mal conductivity detector (TCD) (available for example 
45 from Gow-Mac of Greenbelt Maryland). FIGS. 5 (u)  and (b) 
show a thermal conductivity detector (TCD) used for humid- 
ity monitoring and its circuitry. 
The chambers may be grouped in sets of 10 with each set 
multiplexed to one TCD. The ten chambers fit onto one 
so baseplate (see FIG. 6), which provides structural support for 
the chambers, the valves for each chamber, the multiplexing 
manifolds, and an electrical umbilical. The growth chambers 
may be controlled and monitored by a microcomputer, for 
example a Macintosh Quadra 950 microcomputer using 
55 custom software written in the program language LabView 
to monitor each set of 10 growth chambers, allowing for 
individual or replicate profiles to be executed in any given 
chamber. Data acquisition and interface boards are used for 
all analog and digital inputioutput functions. FIG. 7 provides 
60 a flowchart for a software system useful for carrying out the 
controlling and monitoring functions. 
FIG. 8 shows the crystallization chamber. The crystalli- 
zation chamber is designed to simplify the set up and 
recovery of experiments and can be made of any suitable 
65 material, such as glass, metal or polymeric materials such as 
acrylic polymers and polysulfone. Materials such as acrylics 
that are substantially optically transparent are preferred. The 
35 
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growth solution is deployed as a droplet 40 on a standard 
glass coverslip 42 and placed on the chamber body 46. A 
threaded cap 44 fits over the coverslip, securing it to the 
chamber body. Two O-rings 48 (e.g %6 inch in cross section) 
provide an airtight seal for the chamber when the cap is 
screwed down finger-tight. The chamber body has two 
quick-disconnect valves for connection to the purge gas 
supply and removal lines 50 and 52. This allows removal 
from the baseplate (e.g., for photography) while maintaining 
integrity of the airtight seal. 
The chamber has dual compartments or sections to aid in 
controlling evaporation from the drop surface. The first 
section 54 contains the hanging drop of crystal growth 
solution and can be considered as the crystallization reaction 
section. The second section 56 is in communication with the 
gas supply and removal lines, and solvent evaporating from 
the growth solution is removed by means of the gas supplied 
to and removed from the second section 56. The sections 54 
and 56 are separated by a barrier 58 that acts to prevent any 
substantial direct impingement of the gas on the growth 
solution. However, the barrier permits the passage of evapo- 
rated solvent from the first section to the second section. The 
barrier can be in the form of a washer whose central opening 
permits vapor to pass to the second section while its body 
prevents any substantial flow of gas from the second section 
to the first section. In this case, the washer can be made of 
metal, plastic or any other suitable material. The barrier can 
also take the form of a fabric or membrane made of a 
,903 B2 
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gram also performs all data acquisition functions, digital 
output functions, and writes the cumulative data file to the 
internal hard disk for subsequent analysis. 
EXAMPLE 1 
Hen egg white lysozyme was obtained from Calbiochem. 
NaC1, NaOAc, and glacial acetic acid were obtained from 
Fisher Scientific. A 50 mM acetate buffer was prepared by 
dissolving NaOAc in 18 Mohm deionized water. The pH 
was adjusted to 4.7 using glacial acetic acid. Lysozyme was 
dissolved in buffer and then dialyzed several times against 
fresh buffer to remove any salt from the source protein. This 
solution was then concentrated using Amicon microconcen- 
trators to create a stock solution at 40 mg/mL. A 7% (wiv) 
stock solution of NaCl was prepared by dissolving the NaCl 
salt in buffer. All solutions were filtered through 0.22 micron 
Whatman filters. 
Thaumatin, NaK tartrate, and ADA (N-[2-Acetamido1-2- 
iminodiacetic acid) were obtained from Sigma. Glacial 
acetic acid was obtained from Fisher Scientific. A 68 mg/mL 
stock Thaumatin solution was prepared by dissolving the 
protein in 18 Mohm deionized water. An ADA buffer was 
prepared by dissolving ADA salt in 18 Mohm deionized 
water and adjusting the pH to 6.5 with glacial acetic acid. A 
0.75M stock solution of NaK tartrate was prepared by 
dissolving the NaK tartrate salt in ADA buffer solution. All 
solutions were filtered through 0.22 micron Whatinan filters. 
material or otherwise formed to be permeable to solvent For each protein, lysozyme and thaumatin, the growth 
vapor. In this case, the barrier can extend completely 30 solution was deployed onto silanized glass coverslips by 
between the two sections, without the need for a central mixing 10 microliters of each of the stock protein and 
opening. When water is the solvent, a polymeric material crystallizing agent solutions (20 microliters total). Each 
such as ‘‘GORETEX’ that permits the passage of water coverslip was then placed on a chamber and sealed with a 
vapor can be used for the fabric or membrane. Other useful screw-down cap. Linear evaporation profiles were per- 
materials include a nylon mesh screen material, filter paper 35 formed to determine the effects of evaporation rate on crystal 
or other porous cellulose material, and nucleopore filters. In growth results. Solutions were evaporated at 0.041, 0.083, 
the case of filter paper, it is preferred that the material be one 0.2, 0.34, 0.45, and 1.25 microlitedhr to half the original 
that does not absorb the evaporated solvent. In the case of volume. 
the nucleopore filter, the pore size should be sufficiently Results from a large number of experiments for the two 
large to permit passage of the vapor phase molecules to pass 40 proteins show that clear, systematic trends are observed as a 
therethrough. If the gas flow is permitted to impinge directly function of evaporation rate (see FIGS. 9 (u )  and (b) and 
on the growth solution, the solvent vapor gradient may lO(u) and (b)). As the evaporation rate is increased, larger 
become too steep, resulting in the formation of a large populations of smaller crystals are observed. Since the 
number of nucleation sites (a “shower”) at the solution supersaturation level required for nucleation to occur is 
surface. This is undesirable since it tends to produce large 45 higher than that needed to sustain crystal growth, the 
numbers of small crystals. observed results are likely related to the length of time that 
A microvolume thermal conductivity detector (TCD) is the solution resides in the nucleation region. For a given 
used to quantitate the amount and rate of water evaporated evaporation rate, once nucleation occurs, crystal growth can 
from each growth solution. The difference in thermal con- proceed for those nuclei formed. This crystal growth will 
ductivities between dry N, gas and moist N, gas produces a 50 begin depleting protein from the solution. However, if the 
signal that can be quantitatively related to the amount of supersaturation level is increasing faster due to evaporation 
moisture in the purge volume. The integration of this signal than it is decreasing due to crystal growth, then nucleation 
with respect to time for sequential purges of a given chamber will continue to occur until crystal growth depletes the 
allows the total water evaporated from each chamber to be protein concentration below the supersaturation level 
determined and provides feedback to the host microcom- 5s required for nucleation. Hence, faster evaporation rates 
puter so that virtually any desired evaporation profile may be should maintain a high supersaturation level longer than 
followed. slower evaporation rates, leading to increased crystal popu- 
A custom software program (e.g. as shown in FIG. 7) Mons.  Also, larger crystal PoPulations should generally 
(available from National Instruments of Austin, Tex.) run- 60 growth solution is fixed and cannot sustain crystal growth to 
ning on a Macintosh Quadra 950 (Apple Computer) micro- large sizes for a large number of crystals. 
computer controls all aspects of the system. Auser interface Additionally, comparative x-ray analysis of crystals 
allows various experimental control parameters to be grown using this hardware system with crystals grown by 
entered prior to execution. The program controls the purges traditional methods have been undertaken. Results from the 
of each chamber based upon the evaporation profile entered 65 vapor diffusioninitrogen systems indicate that longer evapo- 
before execution using feedback from the TCD. This allows ration profiles generally produce larger crystals and that the 
virtually any evaporation profile to be followed. The pro- larger crystals generally produce enhanced x-ray diffraction. 
written in the graphical programming language LabVIEW yield smaller crystals since the amount of protein in the 
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Also, crystals of equal size grown at different evaporation Fisher Scientific. A 50 mM acetate buffer was prepared by 
rates show a wide and overlapping variation of diffraction dissolving NaOAc in 18 Mohm deionized water. The pH 
characteristics (signal to noise, resolution). was adjusted to 4.7 using glacial acetic acid. Lysozyme was 
In a second aspect, the present invention can utilize a dissolved in buffer and then dialyzed several times against 
controlifollower system to monitor and control a number of s fresh buffer to remove any salt from the source protein. This 
dynamically controlled vapor diffusion crystallization cham- solution was then concentrated using Amicon microconcen- 
hers (the follower chambers) by means of the infOrmation trators to create a stock solution at 45 mgimL. A 7% (wiv) 
for a sing1e chamber (the chamber). A stock solution of NaCl was prepared by dissolving the salt 
dynamic controlled vapor diffusion controlifollower system in buffer, ~~~~l volumes of the stock protein and NaCl 
(DCVDC/FS) (see “1 has been that pro- i o  solutions were mixed and passed through a filter loop to 
vides dynamic control of the supersaturation level during the produce a solution clean enough to use for laser light 
crystal growth process. This device uses concepts similar to scattering. This loop consisted of a peristaltic pump, tubing, the previously described system that controls supersatura- and a 0.22 micron Whatman filter. The solution was filtered tion levels. The DCVDCiFS system also incorporates a laser 
detecting aggregation events occurring in a growth solution. 200 microliters of the growth solution is deployed in the 
The detection sensor provides feedback to the controlling cuvette, inserted into the chamber assembly and sealed. 
microcomputer so that the evaporation profile can be modi- Initial experiments with this device have revolved around 
fied in real time in an attempt to optimize crystal growth. the use of linear evaporation profiles in the early stages of 
The illustrated system has six growth chambers arranged in the experiment. Once nucleation is detected by the light 
a controlifollower configuration with the control chamber 60 20 scattering system, the profile is modified for half of the 
containing the LLS system which is connected to the humid- chambers, with the original profile continued for the remain- 
itY Sensor (e& a TCD). Some Or all of the remaining der. This allows a direct comparison between the results 
chambers are evaporated at a rate that mimics that of the obtained from continued evaporation at the original linear 
control chamber. rate versus modification of that rate in response to the light 
Each of the Six growth Chambers contain the following 25 scattering sensor. Two different evaporation rates in the early 
components: cuvette, upper glass Purge chamber, three Piece stages of the experiments were investigated. The growth 
chamber solutions were evaporated at 0.83 and 1.389 microliters/hr., 
Griot gered at the detection of nucleation. At this point, half of the 
mamatsu of Bridgewater, N.J.). In the aluminum housing, original evaporation rate (to half the original volume). There the top component is milled out to accomodate the upper 
light scattering (LLS) subsystem as a noninvasive probe for for 30 minutes and then into the cuvettes. 
housing, and thumbscrew. The 
(see 12) contains fiber Optic One for the respectively, until the laser light scattering Sensor was trig- 
Of Imine, and photodetector from Ham- 30 chambers ceased evaporation while half continued at the 
mW2 633 nm He-Ne laser from 
chamber cell and gas flow lines, Additionally, a threaded 
portal is provided through which a thumbscrew any be 
is a distinct change in the 
response as aggregation occurs. This change is 
Of the photodetector 
deployed against the upper chamber cell to sealit against the responded to by the computer the 
cuvette. A cylindrical portal may be milled through the 35 evaporation Profile. Typical experimental Profiles and a 
thumbscrew to provide access for visual observation. The typical response of the Photodetector to aggregation are 
middle component of the aluminum housing is milled shown in FIG. 13. There is a distinct change in the slope of 
through to provide a pathway for the cuvette mid upper- the photodetector response as aggregation occurs. This 
chamber to meet when sealed against each other. This change is subsequently responded to by the computer system 
component essentially acts as a removable spacer to allow 40 that controls the evaporation profile. 
the cuvette to be removed easily from the lower component. Preliminary results for this system indicate that modifi- 
The lower component is milled to accept the cuvette. It also cation of the evaporation profile in response to light scat- 
has portals milled out for two fiber optic cables. A portal tering detection of nucleation yields improved crystalliza- 
through the bottom of the lower component is provided to tion results. Generally, modification of the evaporation 
allow for visual observation. Typically, a light source will 45 profile after nucleation detection, in this case a reduction in 
provide backlight through the bottom of the lower compo- evaporation rate, results in a smaller population of slightly 
nent. larger crystals. A faster initial rate of evaporation also affects 
The growth chamber is a commercially available glass the crystal growth results, yielding a larger population of 
fluorimeter cuvette. The portion of the cell where the actual smaller crystals than observed at the slower initial evapo- 
growth solution is contained has a cross sectional dimension ration rate (FIG. 14). As explained earlier, it is likely that 
of 2 mmxlO mm and is 12.5 mm high. Asecond chamber is growth solutions in which nucleation is detected and evapo- 
sealed on the top of the cuvette to aid in controlling the ration ceased have fewer nuclei, allowing the remaining 
evaporation of water from the growth solution. The two protein in solution to “feed” growth of these crystals to a 
chambers are spearated by a barrier that is permeable to larger size. The growth solutions that continue evaporating 
solvent vapor and substantially prevents any direct impinge- 55 likely reside in a nucleation region longer, producing more 
ment of the purge gas on the growth solution as in the crystals which cannot grow as large. 
previous embodiment. Transmission and detection of the 
laser light is accomplished via optical fibers. The entire 
assembly resides in a three component aluminum housing The Present invention also can be used as a dynamic 
which provides mechanical support for the upper chamber 60 control system that controls the supersaturation state of 
cell and the laser and photo detector fiber optic cables, The materials to be crystallized from solution via precise tem- 
aluminum housing also provides a mechanism for sealing perature changes. Temperature can be Precisely controlled 
the upper chamber to the growth cell (via a thumb screw). and used as a tool to control the Population and size of the 
crystals being obtained, e.g. protein crystals. It also is 
65 possible to use a non-invasive sensor to detect aggregation EXAMPLE 2 
Hen egg white Lysozyme was obtained from Calbiochem. events and modify the temperature program for a given 
NaC1, NaOAc, and glacial acetic acid were obtained from experiment in response to the sensed events. This aspect of 
that 
Temperature Based Systems 
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the present invention also is useful for the controlifollower The growth solution is deployed into a cuvette, which is 
concept. This again is accomplished by monitoring aggre- then placed in the copper jacket and sealed with a cover. 
gation events in the control chamber and controlling the Temperature is controlled using a small TED powered by a 
temperature of the follower chambers in response to the commercial TED controller/power supply (Marlow 
behavior of the experiment in the control chamber. In s Industries) under the direction of a microcomputer. Custom 
general, the Of the growth wlll be software allows user defined temperature programs to be 
lowered or raised (depending upon whether the substance in executed and modified in response to the LLS signal, A 
question shows decreased solubility with lower temperature flowchart for the software system is shown in FIG, 20, 
or higher temperature) until nucleation is initiated. At this 
point, the temperature change can be stopped or reversed to A 'Oftware program as shown in 20) 
inhibit further nucleation that could hinder the growth of 10 written in QuickBasic running on a 486 microcomputer is 
larger crystals. In some cases, it will be desirable to reverse Of the For a Particular 
the temperature change and then hold the solution at a experiment, this Program allows the user to enter the Pre- 
constant temperature when it reaches a desirable tempera- nucleation temperature Profile, the Photodetector signal 
ture for crystal growth. level which designates that aggregation events are 
FIG. 15 is a block diagram of an example of a system for 15 occurring, and the postnucleation temperature profile. The 
protein crystal growth effected by temperature change. This programs can control the temperature profile for the reaction 
diagram outlines the major components for dynamically in any desired manner. For example, one can allow very 
controlled temperature system (DCTS). The sample cham- simple temperature profiles to be executed (SIMPRO) while 
ber in the center circle is instrumented with a thermal the another allows much more complex temperature profiles 
electric device (TED) for temperature change and control 20 to be executed (COMPRO) in an attempt to optimize crystal 
and with laser light scattering via laser probe and detector growth, Examples of thermal profiles that can be used for 
Probe. The system is monitored and controlled via computer. temperature induction of protein crystal growth are shown in 
In this the growth chamber has two comPartments~ FIG. 21. These profiles are generated by the thermal control 
with a laser probe being centered in one of the chambers. computer software developed in house, simple straight 
can be designed with the software. The software/ in FIG. 15. 
adjustments to initiate, monitor, and control the growth of functions, recording the data files to an internal hard disk, 
protein crystals. Temperature is manipulated via miniature The temperature based system can be applied to any thermoelectric devices (TEDs) under computer control to 30 material to be crystallized. It is believed to be particularly change the temperature in virtually any desired manner. useful for macromolecular materials such as proteins, Detection of aggregation events is accomplished using a nucleic acids and virus particles, especially proteins. In static laser light scattering system (LLS), which acts as a addition, it should be recognized that the proteins that will sensor to provide feedback to the controlling microcom- be most suitable for temperature controlled crystallization puter. All aspects of the systems are monitored and adjusted 35 are those that show a AB,,/AT value of at least 2xlO-' mol by a 486 microcomputer containing a data acquisition inter- ml/g2 deg, where B is the osmotic second virial coefficient, face card. Custom software written in QuickBASIC allows a measure of protein-protein specific interactions in a spe- the user to set a particular temperature program for a given cific solution condition. Examples include lysozyme, hen eg experiment. albumin, pepsin, alpha-chymotrysinogen A, equine serum 
to 
l6 is an expanded view Of the growth system depicted 25 forward profiles (Simpro) and complex profiles (Cornpro) 
As shown in FIG. 17, this system uses Precise temperature microcomputer perform all control and data acquisition 
An 
Of the DCTS apparatus is shown schemati- 40 albumin, bovine serum albumin, thaumatin, neurophysin- 
cally in 18. The copper jacketed chamber dipeptide complex, bovine insulin (T3R3), &stin, porcine 
houses a lo mm glass cuvette (Starna Cells, Inc.3 insulin (T3R3) and human insulin-4-hydroxybenzamide. 
Atascadero, Calif.) which contains 200 microliters of the 
appropriate growth medium. Generally, a volume of at least 
50 micorliters is needed since it can be difficult to couple the 45 
laser into a smaller volume. The use of a container for the Chicken egg white lysozyme was obtained from Calbio- 
growth solution permits better thermal contact and resultant &em. Bovine insulin (Pancreas), and Porcine insulin 
improvement in temperature control for the solution. The (pancreas) were obtained from Sigma. All Proteins were 
copper-jacketed nucleation chamber is surrounded by Teflon used as received without further purification. Zinc acetate 
encased in an aluminum block. The nucleation chamber, in SO dihydrate was obtained from Sigma Chemical Company. 
conjunction with a Marlow 5000 series temperature control- Acetone, trisodium citrate sodium acetate trihydrate, and 
ler (available from Marlow Industries, Dallas, Tex.), an IBM sodium chloride (all certified, ACS reagent grade) were 
compatible p c ,  thermoelectric device, and type T obtained from Fisher Scientific. Lysozyme was crystallized 
thermocouple, allow precise temperature control of the using solubility data collected by CacioPPo and PuseY. The 
protein growth medium. The static laser light scattering ss crystallizing medium consisted of 25 W / m L  of lysozyme 
EXAMPLE 3 
geometry is also shown, Laser light from a helium-neon 633 
nm, 5 mW Melles Griot laser is directed into the protein 
solution via a fiber optic cable, A second fiber optic cable is 
and 2.5% sodium chloride in 50 mM sodium acetate buffer 
at pH=4.4. Both bovine and porcine insulins were crystal- 
lized from 0.05M trisodium citrate and 0.0075M zinc acetate 
placed at 90" to the incident laser fiber and collects scattered in the Presence of 0.75M sodium chloride, 15% acetone, and 
light that is carried to a photodetector. The output of the 60 5% water at PH=6.4 (M. M. Harding, et al. (1966) J. Mol. 
photodetector is returned to the controlling CPU in the form Bid.  16, 30:323-327). All growth media were centrifuged 
of an analog signal. The controlling CPU compares voltages and filtered Prior to use. 
and modifies temperatures as defined by the experimental Temperature-induced bulk crystallization was accom- 
parameters. The nominal error for temperature control asso- plished by incubating the crystallizing medium at an initial 
ciated with this experimental set up is 20.1" C. with a 65 temperature at which the protein is in a quasi-equilibrium 
maximum error of 20.25" C. A circuit diagram of a particu- state. At this temperature, aggregate size distribution is 
larly useful temperature control system is shown in FIG. 19. stable and stable baseline voltages are obtained. After steady 
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state data were accumulated, temperature was decreased at reagnets were added in the order liseted: 150 microliters of 
programmed rates to increase the level of supersaturation 0.15M zinc acetate, 750 microliters of 0.2M trisodium 
and affect protein aggregation. The aggregation event was citrate, 510 micorliters of acetone, 90 microliters of water, 
defined as a percentage above steady state voltage. After and 0.18 g of sodium chloride. The pH was adjusted to 6.4 
aggregation was observed, the temperature was increased at 5 and the solution was heated for a few minutes at 40" C. to 
programmed rates to a final growth temperature. ensure that all medium components were in solution. The 
The present system successfully used static laser light growth medium was centrifuged for one hour at 40" C., 
scattering to detect the aggregation of lysozyme and effec- filtered over an Anotop filter and then incubated at 40" C. in 
tively to &couple the nucleation and growth phases of the nucleation chambers for one hour. Then the temperature 
lysozyme crystal growth. This was accomplished by induc- was decreased from 40" c .  to 10" c .  at a rate of 0.02" 
ing nucleation at low temperature/high supersaturation C./min. After nucleation was detected ( 1 . 1 5 ~  baseline 
conditions, observing an increase in the total intensity of the voltage), the temperature was increased to the final growth 
scattered light as measured by SLS, and increasing the temperature of 28" C. at a rate of 0.5" C./min. This resulted 
temperature to dissociate some of the aggregates and pro- in a large population of 0.1 mmx0.l mm crystals by day 6 
vide for a better environment for the growth of remaining 15 of incubation at the final growth temperature 
aggregates. The change in scattering voltage with respect to With reference to FIG. 24(c), porcine insulin (Sigma, 10 
temperature changes is shown in the double Y graphs of FIG. mg) was dissolved in 1.5 mL of 0.02M HC1. The following 
22. These graphs depict detector voltage and temperature reagents were added in the order listed: 150 microliters of 
versus experiment time. These representative plots all show 0.15M zinc acetate, 750 microliters of 0.2M trisodium 
that scattering voltage (particle size) increases with decreas- 2o citrate, 510 microliters of acetone, 90 microliters of water, 
ing temperature (protein aggregation) and that the onset of and 0.18 g of sodium chloride. The pH was increased to -9 
voltage increase is directly correlated with the decrease in with microliter amounts of dilute sodium hydroxide to 
temperature. As the temperature is increased, particle size solubilize all components and then the solution was back- 
decreases (aggregates dissociate) and the decrease in the titrated to pH=6.4 with dilute hydrochloric acid. The solu- 
magnitude of the scattering voltage is correlated with the 25 tion was centrifuged for one hour at 40" C., filtered over an 
onset of the temperature increase. Crystal populations and Anotop filter, incubated at 22" C. in the nucleation chamber 
morphologies obtained from the experiments described in for one hour and then the temperature was decreased from 
FIG. 22 are shown in the micrographs of FIG. 23. 40" C. to 10" C. at a rate of 0.5" C./min. After nucleation was 
These photomicrographs clearly demonstrate that aggre- detected (this was set at 1 . 1 5 ~  baseline voltage that was 
gation at a low temperature/high supersaturation condition 30 accumulated during the one hour incubation at 40" C.), the 
followed by an increase in temperature to an environment of temperature was increased to the final growth temperature of 
lower protein supersaturation affects the population of 28" C. at a rate of 0.5" C./min. A small population of 0.25 
microscopic crystals produced. Approaches to both the mmx0.20 mm crystals were obtained after one day at the 
nucleation temperature (the temperature where aggregation final growth temperature. 
first occurs) and the final growth temperature affect both the 35 With reference to FIG. 24(d), porcine insulin (Sigma, 10 
number of microcrystals produced at the nucleation tem- mg) was dissolved in 1.5 mL of 0.02M HC1. The following 
perature and the number of microcrystals that are dissociated reagents were added in the order listed: 150 microliters of 
when the temperature is increased. Porcine and bovine 0.15M zinc acetate, 750 microliters of 0.2M trisodium 
insulins were also crystallized by DCIPCGT. Static light citrate, 510 microliters of acetone, 90 microliters of water, 
scattering data demonstrates that insulin aggregates rapidly 40 and 0.18 g of solid sodium chloride. The pH was increased 
with decreasing temperature and that the particle size dis- by the addition of microliter amounts of dilte sodim hydrox- 
tribution could be reversed with an increase in temperature. ide to solubilize all medium components and then backti- 
This is shown in FIG. 24(a)-(d). Small populations of trated with microliter amounts of dilute hydrochloric acid to 
insulin crystals ranging in size from 0.2 to 0.4 mm were pH=6.4. The mediuk was centrifuged at room temperature, 
produced. Details of the experimental conditions are pre- 45 filtered over an Anotop filter and incubated at 30" C. for one 
sented below. hour in the nucleation chambers. The temperature was 
With reference to FIG. 24(a), Bovine insulin (Sigma, 10 decreased to the nucleation temperature of 10" C. at a rate 
mg) was dissolved in 1.5 mL of 0.02M HC1. The following of 0.05" C./min. After nucleation was detected ( 1 . 1 5 ~  base- 
reagents were added in the order listed: 150 microliters of line voltage), the temperature was increased to the final 
0.15M zinc acetate, 750 microliters of 0.2M trisodium 50 growth temperature of 28" C. at a rate of 0.25" C./min. A 
citrate, 510 microliters of acetone, 90 microliters of water, small population of crystals measuring 0.3 mmx0.3 mm was 
and 0.18 g of sodium chloride. The pH was increased to obtained after five days of incubation at the final growth 
about 11 with microliter volumes of dilute sodium hydroxide temperature. 
to solubilize all medium components and then was backti- FIG. 25 presents data collected from the temperature 
trated to 6.4 with microliter amounts of dilute hydrochloric 5s induction system of Example 3 on the protein, neurophysin. 
acid. The medium was heated at 40" C. for several minutes As the ramp rate decreased, or in other words, as the 
and then centrifuged at room temperature for one hour. The temperature change occurred over a longer period of time, 
growth medium was incubated at 22" C. in the nucleation the crystal size increased. 
chambers and then the temperature was decreased to 10" C. Thus, static laser light scattering is one example of a 
at a rate of 0.5" C./min. After nucleation was detected ( 1 . 1 5 ~  60 system that can be used to detect the aggregation of 
baseline voltage), the temperature was increased to the final lysozyme and insulin, and the particle size response of these 
growth temperature of 28" C. at a rate of 0.5" C./min. A proteins to changes in temperature is rapid. This allows a 
small population of crystals measuring 0.2 mmx0.2 mm was decoupling of the nucleation and growth stages of crystal 
obtained after four days of incubation at the final growth growth. In addition, these results demonstrate that tempera- 
temperature. 65 ture can have a profound effect on the population and size of 
With reference to FIG. 24(b), bovine insulin (Sigma, 8 crystals that are obtained for a given experiment. The rate at 
mg) was dissolved in 1.5 mL of 0.02M HC1. The following which the temperature is changed as well as the target 
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nucleation temperature both can affect the size and popula- 
tion of crystals obtained for a given protein. This effect has 
been examined for several different proteins including 
lysozyme, insulin and insulin complexes (from different 
species), and neurophysin. Results from the temperature 
induction studies and systems indicate it is possible to 
demonstrate that crystal nucleation can be detected by laser 
light scattering in microliter volume samples and can be 
reversed via temperature change (a decreased, where a is 
the ratio of protein concentration over protein solubility). 
The results show that nucleation temperature varies in a 
qualitative way that is predictable and reproducible as a 
function of protein solution variables. They also demon- 
strate that it is possible to investigate various post-nucleation 
growth profiles by dynamically controlling temperature to 
change a. In the temperature induction studies, we found 
that the change in the baseline scattering definition that 
triggers a change in temperature profile(s) varied from 15% 
to 45% of the light scattering background. In these studies, 
T,,, definition is the target nucleation temperature. It was 
found that large aggregateinuclei were more difficult to 
dissociate and that lower T,,, definition resulted in fewer, 
larger crystals. 
FIGS. 26 and 27 show a temperature based dynamic 
control system incorporating the basic technical features 
described above, but does differ in some of the specific 
hardware. Temperature is controlled with a programmable 
water bath while the growth chamber may be a 200 micro- 
liter polysulfone cylinder. It includes a controlifollower 
arrangement to investigate the reproducibility of crystals 
grown by temperature in which the status of one chamber is 
used to determine the actions taken on other chambers. The 
control chamber incorporates the static laser light scattering 
system for detecting aggregation events, while the three 
follower chambers do not. The crystallization chambers are 
housed in an insulated container, which circulates water 
from a programmable water bath to control the temperature. 
The previously described custom software (SIMPRO or 
COMPRO) is used to drive the experiments. 
A thermocouple provides temperature feedback to the 
host microcomputer. The incident laser beam enters the 
control growth chamber from the bottom of the growth 
chamber through a fiber optic cable. Scattered light is 
collected at 90" to the incident beam via a second fiber optic 
cable that is carried to a photodetector. Foam insulation 
surrounds the assembly to maintain a given temperature 
during a reaction. 
EXAMPLE 4 
Hen egg white lysozyme was obtained from Calbiochem. 
NaC1, NaOAc, and glacial acetic acid were obtained from 
Fisher Scientific. A 50 mM acetate buffer was prepared by 
dissolving NaOAc in 18 Mohm deionized water. The pH 
was adjusted to 4.7 using glacial acetic acid. Lysozyme was 
dissolved in buffer and then dialyzed several times against 
fresh buffer to remove any salt from the source protein. This 
solution was then concentrated using Amicon microconcen- 
trators to create a stock solution at 120 mgimL. A 4% (wiv) 
stock solution of NaCl was prepared by dissolving the salt 
in buffer. Equal volumes of the stock protein and NaCl 
solutions were mixed and centrifuged for one hour. The 
supernatant was then filtered through a 0.2 micron Anotop 
filter. 
160 microliters of the growth solution is deployed into 
each growth cell, and then the cells are inserted into the 
chamber assembly and sealed with caps. From the initial 
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temperature T1 (22" C. in this example) the temperature is 
ramped at some rate R1 (0.5" C./minute down in this 
example) towards the target nucleation temperature T2 (3" 
C. in this example). If nucleation is detected by the LLS 
s system, then the temperature ramp is modified before reach- 
ing the target temperature. Upon detecting nucleation or 
reaching the target nucleation temperature, the temperature 
is then ramped at some rate R2 (0.5" C./minute up in this 
example) to a final growth temperature T3 (13" C. in this 
i o  example). Other more complex temperature profiles are 
possible as defined by the experimenter. 
Initial experiments with this system were performed with 
two proteins, lysozyme and thaumatin. The results obtained 
using this system demonstrate good reproducibility between 
15 cells run under identical conditions (FIG. 28). Both the 
number and size of crystals obtained are similar in all four 
cells. This demonstrates that a controlifollower arrangement 
can be used with success to grow crystals of comparable size 
and quantity in several different cells while actively moni- 
20 toring (with static laser light scattering, LLS) only one of the 
identically controlled cells. This approach eliminates the 
need to use multiple sensors to control duplicate (identical) 
experiments. 
It can be seen that the present invention can utilize two 
25 methods, vapor diffusion and temperature, to control the 
nucleation and growth of protein crystals. Either method can 
be used successfully to gain control over the crystal growth 
process in a manner previously unavailable. 
The vapor diffusion approach has shown that varying the 
evaporation rate of the growth solutions systematically 
affects the size and number of the crystals obtained. Faster 
evaporation rates generally lead to larger populations of 
smaller crystals than slower evaporation rates. Inclusion of 
35 a non-invasive sensor (LLS) has been used to detect 
aggregation, at which point the initial evaporation rate is 
modified, resulting in a smaller population of larger crystals 
than obtained without dynamic response. These results are 
likely related to the length of time that a given growth 
4o solution resides at a supersaturation level where nucleation 
occurs. 
The temperature based protein crystal growth systems 
follow an approach where the crystal growth solution is 
maintained in a container, rather than as a hanging drop, and 
45 use precise control of temperature via TED'S or a water bath 
to induce nucleation and control crystal growth. A static 
laser light scattering system is used as a diagnostic to detect 
aggregation and the temperature modified to optimize crys- 
tal growth. A controlifollower configuration has been used 
so whereby information obtained by monitoring one chamber 
can be used to effect similar results in the remaining cham- 
bers. 
While the present invention is useful for terrestial crystal 
growth, development of these systems for microgravity 
ss studies should improve the success of protein crystal growth 
on the space shuttle and/or the international Space Station. 
The flight experiment would be via a dynamically controlled 
protein crystal growth technique which uses either of the 
two methods, vapor equilibration or temperature, to control 
60 and optimize the crystallization process. This would be 
accomplished by controlling supersaturation prior to and 
after the nucleation event, which can be detected via laser 
light scattering. Video information can also be used to 
evaluate crystal data so that subsequent experiments could 
65 be altered in an attempt to optimize results. FIGS. 29 and 30 
are respectively diagrams of examples of the system inter- 
faces for the vapor diffusion systems (DCIPCG-V) and the 
3o 
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temperature systems (DCIPCG-T) with the Space Shuttle 
(STS). The systems used for space shuttle work should be 
made with components approved under the relevant NASA 
guidelines. In FIG. 26, the indication STES stands for Single 
Thermal Enclosure System, which also is known as CRIM. 
While a detailed description has been provided above, the 
present invention is not limited thereto, but rather is defined 
by the following claims. 
What is claimed is: 
1. An apparatus for crystal growth, comprising: 
a growth chamber comprising a first section for contain- 
ing a solution comprising a substance to be crystallized 
and a solvent for the substance to be crystallized and a 
second second divided from the first section, whereby 
evaporation of the solvent from the solution causes 
crystallization of the substance to be crystallized from 
solution; 
a gas flow source in communication with the second of the 
growth chamber, for providing a gas flow to remove 
evaporated solvent vapor from the growth chamber; 
and 
a gas flow source control for changing the gas flow rate to 
the growth chamber. 
2. An apparatus according to claim 1, further comprising 
an aggregation or nucleation detector for determining the 
onset of aggregation or nucleation in the solution and 
creating a signal for the gas flow source control to change 
the gas flow rate in response to the onset of aggregation or 
nucleation. 
3. An apparatus according to claim 1, further comprising 
a barrier between the first and second sections for preventing 
any substantial impingement of the gas flow on the solution 
in the first section. 
4. An apparatus according to claim 3, wherein the barrier 
is a plate with a central opening. 
5. An apparatus according to claim 3, wherein the barrier 
is a membrane that is permeable to the solvent vapor. 
6. An apparatus according to claim 1, wherein the gas is 
nitrogen. 
7. An apparatus according to claim 1, further comprising 
a detector for solvent vapor removed from the growth 
chamber. 
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8. An apparatus according to claim 1, wherein the solvent 
is water and the apparatus comprises a sensor for measuring 
humidity of gas removed from the growth chamber. 
9. An apparatus according to claim 1, wherein the sub- 
s stance to be crystallized is selected from the group consist- 
ing of a protein, a polypeptide, a nucleic acid, a virus and a 
virus fragment. 
10. A method of growing crystals, comprising: 
providing in a first section of a growth chamber a solution 
comprising a solvent in which a substance to be crys- 
tallized is dissolved, whereby solvent can evaporate 
from the solution; 
supplying a gas flow to a second section of a growth 
chamber, the second section being divided from the 
first section, to remove evaporated solvent from the 
growth chamber, whereby evaporation of the solvent 
from the solution causes crystallization of the substance 
to be crystallized from the solution; and 
analyzing the solution during evaporation of the solvent to 
detect an onset of nucleation and changing the gas flow 
rate upon detection of the onset nucleation. 
11. The method of claim 10, wherein direct infringement 
of the gas flow on the solution is substantially prevented. 
12. The method of claim 10, wherein the substance to be 
crystallized is selected from the group consisting of a 
protein, a polypeptide, a nucleic acid, a virus and a virus 
13. The method of claim 12, wherein the substance to be 
14. The method of claim 12, wherein the substance to be 
15. The method of claim 12, wherein the substance to be 
16. The method of claim 12, wherein the substance to be 
17. The method of claim 12, wherein the substance to be 
i o  
20 
2s 
30 fragment. 
crystallized is a protein. 
crystallized is a polypeptide. 
crystallized is a nucleic acid. 
crystallized is a virus. 
crystallized is a virus fragment. 
3s 
4o 
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